Swaminathan Revathl MD entered the industry of Doctors in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Doctors. The business provides service to the B2C market.
To acquire more information, please contact Revathl Swaminathan by calling (309) 692-2337 during business hours. You can also write to the business’ Single Location at 7309 North Knoxville Avenue # 300, Peoria, Illinois IL 61614. You can also visit the company’s website at ciradiationoncology.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Swaminathan Revathl MD |
| Representative: | Revathl Swaminathan |
| Place of Business: | 7309 North Knoxville Avenue # 300, Peoria, IL 61614 |
| Contact Number: | (309) 692-2337 |
| Website: | ciradiationoncology.com |
| Type of Service: | Doctors |
| SIC Number: | 8011 |
| NAICS Number: | 6211110 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Income/Year: | $500.000 to $999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Swaminathan Revathl MD is a company operating from Peoria, Illinois providing professional Doctors and relevant B2C variables. It was founded in 0 and registered with the SIC code 8011 as Doctors, and with the NAICS code 6211110 as Doctors.
With a current employee count of 1 to 4, Swaminathan Revathl MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Revathl Swaminathan at (309) 692-2337 for related queries, or to locate its Single Location using the coordinates 40.77631,-89.60266.
The Single Location can also be found at the street address 7309 North Knoxville Avenue # 300 in Peoria, Illinois 61614 and can be engaged online through the company website at ciradiationoncology.com, the company Twitter , and Facebook page .